Search
Revvity Inc
RVTYAdd to Watchlist
100.000USD
+2.170+2.22%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
11.16BMarket Cap
48.03P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-18The current earnings forecast score of Revvity Inc is 7.22, ranking 148 out of 203 in the Healthcare Equipment & Supplies industry. The average price target is 110.00, with a high of 135.00 and a low of 85.00.
Analyst Rating
Based on
18
analysts
Buy
Current Rating
115.437
Target Price
+18.01%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
94
Total
3
Median
7
Average
Company name
Ratings
Analysts
Revvity Inc
RVTY
18
Boston Scientific Corp
BSX
37
Intuitive Surgical Inc
ISRG
35
Edwards Lifesciences Corp
EW
34
Thermo Fisher Scientific Inc
TMO
30
Veeva Systems Inc
VEEV
29
1
2
3
...
19
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Revvity Inc's expected revenue for the next quarter?
Revvity Inc's expected revenue is 710.46M.
What is Revvity Inc's price target?
Analysts forecast that Revvity Inc's price target is USD 110.00, with the highest forecast at USD 135.00 and the lowest forecast at USD 85.00.
How have Revvity IncRVTY's recent earnings per share performed?
The market expectation was USD 0.36, while Revvity IncRVTY's earnings per share (EPS) for the previous quarter was USD 0.87. EPS for the next quarter is expected at USD 1.22.
What is the analyst rating for Revvity Inc?
Based on the ratings of Revvity Inc's stock from 18 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
